Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034163852> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2034163852 endingPage "605" @default.
- W2034163852 startingPage "597" @default.
- W2034163852 abstract "THE RESULTS OF a Phase II clinical trial of intrathecal recombinant tissue-type plasminogen activator for the prevention of vasospasm were reported. The subjects were 53 patients with aneurysmal subarachnoid hemorrhage (SAH), Groups 2 to 4 in Fisher's preoperative computed tomography classification and Grades II to IV in the Hunt-Kosnik classification. Twenty-four hours after surgery, tissue-type plasminogen activator (TD-2061) was intracisternally administered via a catheter (0.1, 0.2, or 0.4 mg, three times daily for 5 days). The clot-dissolving effects assessed as “effective” and “markedly effective” were virtually the same in the 0.1- and 0.2-mg groups (66.7% and 64.3%, respectively) but slightly lower (53.3%) in the 0.4-mg group, suggesting an adequate effect in the 0.1- and 0.2-mg groups. Severe angiographic vasospasm was not observed in any of three groups. No intergroup differences were noted in the incidence of symptomatic vasospasm, low density on computed tomography 1 month after SAH, and functional prognosis. Bleeding complications were noted in 4 patients (7.5%), including 1 case of SAH in the low 0.1-mg group, 2 cases of SAH in the 0.2-mg group, and 1 case of epidural hematoma in the 0.4-mg group. In overall safety rating, 3 cases with increased SAH and 1 case of epidural hematoma were assessed as “safety doubtful.” Other minor side effects such as headache and hepatic dysfunction attributed to the effect of other simultaneously used drugs were assessed as “almost safe,” and the rate of “almost safe” and “better” for all dose groups was about 90%, suggesting a safe dose level for all groups. These results suggest that repeated intrathecal administration of tissue-type plasminogen activator is useful for preventing vasospasm even in the low dose of 0.1 mg." @default.
- W2034163852 created "2016-06-24" @default.
- W2034163852 creator A5002589477 @default.
- W2034163852 creator A5012858671 @default.
- W2034163852 creator A5021702842 @default.
- W2034163852 creator A5025185461 @default.
- W2034163852 creator A5026539072 @default.
- W2034163852 creator A5028928791 @default.
- W2034163852 creator A5031781647 @default.
- W2034163852 creator A5062983106 @default.
- W2034163852 creator A5082662156 @default.
- W2034163852 creator A5084941435 @default.
- W2034163852 creator A5087835574 @default.
- W2034163852 creator A5090955736 @default.
- W2034163852 date "1994-10-01" @default.
- W2034163852 modified "2023-09-30" @default.
- W2034163852 title "A Phase II Clinical Trial of Recombinant Human Tissue-type Plasminogen Activator against Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage" @default.
- W2034163852 cites W147820283 @default.
- W2034163852 cites W1574261673 @default.
- W2034163852 cites W1874700596 @default.
- W2034163852 cites W1969850797 @default.
- W2034163852 cites W1980946806 @default.
- W2034163852 cites W1986984890 @default.
- W2034163852 cites W1996305850 @default.
- W2034163852 cites W2006907998 @default.
- W2034163852 cites W2009801453 @default.
- W2034163852 cites W2024899764 @default.
- W2034163852 cites W2025663530 @default.
- W2034163852 cites W2046437727 @default.
- W2034163852 cites W2060752639 @default.
- W2034163852 cites W4238605326 @default.
- W2034163852 doi "https://doi.org/10.1227/00006123-199410000-00004" @default.
- W2034163852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7808602" @default.
- W2034163852 hasPublicationYear "1994" @default.
- W2034163852 type Work @default.
- W2034163852 sameAs 2034163852 @default.
- W2034163852 citedByCount "58" @default.
- W2034163852 countsByYear W20341638522013 @default.
- W2034163852 countsByYear W20341638522015 @default.
- W2034163852 countsByYear W20341638522018 @default.
- W2034163852 countsByYear W20341638522019 @default.
- W2034163852 crossrefType "journal-article" @default.
- W2034163852 hasAuthorship W2034163852A5002589477 @default.
- W2034163852 hasAuthorship W2034163852A5012858671 @default.
- W2034163852 hasAuthorship W2034163852A5021702842 @default.
- W2034163852 hasAuthorship W2034163852A5025185461 @default.
- W2034163852 hasAuthorship W2034163852A5026539072 @default.
- W2034163852 hasAuthorship W2034163852A5028928791 @default.
- W2034163852 hasAuthorship W2034163852A5031781647 @default.
- W2034163852 hasAuthorship W2034163852A5062983106 @default.
- W2034163852 hasAuthorship W2034163852A5082662156 @default.
- W2034163852 hasAuthorship W2034163852A5084941435 @default.
- W2034163852 hasAuthorship W2034163852A5087835574 @default.
- W2034163852 hasAuthorship W2034163852A5090955736 @default.
- W2034163852 hasConcept C126322002 @default.
- W2034163852 hasConcept C141071460 @default.
- W2034163852 hasConcept C2776531899 @default.
- W2034163852 hasConcept C2776572282 @default.
- W2034163852 hasConcept C2776820941 @default.
- W2034163852 hasConcept C2777736543 @default.
- W2034163852 hasConcept C2778506911 @default.
- W2034163852 hasConcept C2779662492 @default.
- W2034163852 hasConcept C2779679481 @default.
- W2034163852 hasConcept C2909373784 @default.
- W2034163852 hasConcept C42219234 @default.
- W2034163852 hasConcept C71924100 @default.
- W2034163852 hasConceptScore W2034163852C126322002 @default.
- W2034163852 hasConceptScore W2034163852C141071460 @default.
- W2034163852 hasConceptScore W2034163852C2776531899 @default.
- W2034163852 hasConceptScore W2034163852C2776572282 @default.
- W2034163852 hasConceptScore W2034163852C2776820941 @default.
- W2034163852 hasConceptScore W2034163852C2777736543 @default.
- W2034163852 hasConceptScore W2034163852C2778506911 @default.
- W2034163852 hasConceptScore W2034163852C2779662492 @default.
- W2034163852 hasConceptScore W2034163852C2779679481 @default.
- W2034163852 hasConceptScore W2034163852C2909373784 @default.
- W2034163852 hasConceptScore W2034163852C42219234 @default.
- W2034163852 hasConceptScore W2034163852C71924100 @default.
- W2034163852 hasIssue "4" @default.
- W2034163852 hasLocation W20341638521 @default.
- W2034163852 hasLocation W20341638522 @default.
- W2034163852 hasOpenAccess W2034163852 @default.
- W2034163852 hasPrimaryLocation W20341638521 @default.
- W2034163852 hasRelatedWork W1967556067 @default.
- W2034163852 hasRelatedWork W2004219333 @default.
- W2034163852 hasRelatedWork W2034163852 @default.
- W2034163852 hasRelatedWork W2052515343 @default.
- W2034163852 hasRelatedWork W2056731836 @default.
- W2034163852 hasRelatedWork W2128533739 @default.
- W2034163852 hasRelatedWork W2326632012 @default.
- W2034163852 hasRelatedWork W2334581929 @default.
- W2034163852 hasRelatedWork W2371368900 @default.
- W2034163852 hasRelatedWork W4246468812 @default.
- W2034163852 hasVolume "35" @default.
- W2034163852 isParatext "false" @default.
- W2034163852 isRetracted "false" @default.
- W2034163852 magId "2034163852" @default.
- W2034163852 workType "article" @default.